Plasma endocannabinoids correlate positively with markers of obesity and metabolic disorders [89,90], and alterations to the genes encoding CB1, CB2, and FAAH have been associated, respectively, with metabolic syndrome and overweight and obesity [85,91]. The gene discussed is FAAH; the disease is obesity disorder.